About Kowa Pharmaceuticals
Who we are
Kowa Pharmaceuticals America, Inc. is a U.S. pharmaceutical company headquartered in Montgomery, Alabama, with a growing focus on eye care and ophthalmology. Building on a longstanding heritage in cardiometabolic and anti-inflammatory therapeutics, we are concentrating our resources on therapies that help preserve and protect vision while continuing to support appropriate use of select legacy products.
Kowa Pharmaceuticals America, Inc.
Established in 2008, Kowa Pharmaceuticals America, Inc. is part of Kowa Company, Ltd. and is committed to continuing the development and commercialization of safe and effective healthcare solutions for our current and near-term portfolio of pharmaceutical products and business development activities.
Established in 1894, Kowa is actively engaged in various manufacturing and trading activities in the fields of pharmaceuticals, textile, machinery, construction materials, chemicals, commodities and hospitality.
WE ARE:
A pharmaceutical company with a history of doing things with passion while elevating the value of brands from all over the U.S.
Powered by a strong history of compliance and the desire to ensure patients get the best treatment options available
Proudly developing a workforce skilled at overcoming day-to-day complexities while also empowered to make a tangible difference in their respective roles and across the company
Focused on results
Kowa Research Institute
Spearheading the clinical development of Kowa Company's new drugs in the United States.
Kowa Science Institute
Exploring new approaches to targeting discoveries that can speed up the translation of basic science findings into the clinic as new therapies.
Kowa Company, Ltd.
A privately held, multinational company headquartered in Nagoya, Japan, and established in 1894 as a textile wholesaler. Over more than 130 years, Kowa has grown into a diversified group, actively engaged in manufacturing and trading across pharmaceuticals, textiles, machinery, construction materials, chemicals, commodities, and hospitality, continually evolving to meet changing societal needs. Kowa's pharmaceutical division is focused on research and development in cardiovascular therapeutics (including dyslipidemia, type 2 diabetes, and atherosclerosis), ophthalmology, and anti-inflammatory agents. Learn more about the history of Kowa Group.
Our Mission
Driven to improve patients' lives by providing safe, effective therapies while supporting the eye care providers who serve them.
Fostering a culture of doing things with passion while prioritizing compliance, integrity, and scientific excellence in everything we do.
Our team
Our leadership team combines deep experience in pharmaceuticals, eye care, and cardiometabolic medicine. Together, with representatives from the global Kowa organization, they guide our U.S. strategy, uphold our commitment to compliance, and foster a culture that puts patients and providers at the center of every decision.
Joe Barna
Chairman, CEO & President
Kowa Pharmaceuticals America, Inc.
Shigeru Kimura
Representative Director Executive / Vice President
Kowa Company, Ltd.
Hitoshi Kinouchi
Executive Officer / Senior Manager Ethical Products / International Sales & Marketing
Kowa Company, Ltd.
Kazumasa Nishijima
Executive Officer / Factory Manager, Mohka Factory, Production & Distribution Division / Pharmaceutical Business Unit
Kowa Company, Ltd.
Craig A. Sponseller, MD
Chief Medical Officer
Kowa Pharmaceuticals America, Inc.
Tadashi Edamatsu
Business Coordinator Director
Kowa Company, Ltd.